Cargando…

Serum miR-4488 as a potential biomarker of lean nonalcoholic fatty liver disease

BACKGROUND: In lean individuals, nonalcoholic fatty liver disease (NAFLD) is not a benign disease, and these patients have long-term morbidity and mortality similar to those of their nonlean counterparts. Finding biomarkers for noninvasive and early detection is urgent and microRNAs (miRNAs) show po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Nan, Tang, Ling, Qian, Yufan, Pan, Jielu, Pan, Jiashu, Miao, Hongyu, Zhang, Haiyan, Fang, Hong, Yu, Xiao, Xing, Lianjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009574/ https://www.ncbi.nlm.nih.gov/pubmed/36923095 http://dx.doi.org/10.21037/atm-22-6620

Ejemplares similares

The Efficacy and Safety of Traditional Chinese Medicine (Jiang Zhi Granule) for Nonalcoholic Fatty Liver: A Multicenter, Randomized, Placebo-Controlled Study
por: Pan, Jielu, et al.
Publicado: (2013)

4488 Neural Network of the Cognitive Model of Reading
por: Posner, Joseph, et al.
Publicado: (2020)

Jiang Zhi Granule protects immunological barrier of intestinal mucosa in rats with non-alcoholic steatohepatitis
por: Yu, Xiao, et al.
Publicado: (2021)

Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin
por: Castaldo, Vittorio, et al.
Publicado: (2023)

Lean nonalcoholic fatty liver disease and sarcopenia
por: Chen, Milian, et al.
Publicado: (2023)

Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
por: Han, Eugene, et al.
Publicado: (2023)

Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2023)

Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease
por: Zeng, Jing, et al.
Publicado: (2020)

Association between Serum Uric Acid to HDL-Cholesterol Ratio and Nonalcoholic Fatty Liver Disease in Lean Chinese Adults
por: Zhang, Ya-Nan, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management
por: Chrysavgis, Lampros, et al.
Publicado: (2020)

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
por: Kim, Yuna, et al.
Publicado: (2022)

Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
por: Ishido, Shun, et al.
Publicado: (2023)

Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease
por: Jiang, Yuanye, et al.
Publicado: (2023)

Plasma-Derived Exosomal hsa-miR-4488 and hsa-miR-1228-5p: Novel Biomarkers for Dermatomyositis-Associated Interstitial Lung Disease with Anti-Melanoma Differentiation-Associated Protein 5 Antibody-Positive Subset
por: Zhong, Danli, et al.
Publicado: (2021)

Caffeine intake interacts with Asian gene variants in Parkinson's disease: a study in 4488 subjects
por: Ong, Yi-Lin, et al.
Publicado: (2023)

Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
por: Chun, Ho Soo, et al.
Publicado: (2023)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Comparison of clinical characteristics between lean and obese nonalcoholic fatty liver disease in the northeast Chinese population
por: Li, Hui, et al.
Publicado: (2019)

Predictive Risk Factors of Nonalcoholic Fatty Liver Disease in a Lean Chinese Population
por: Liu, Lu, et al.
Publicado: (2022)

Exosomal miR-4488 and miR-1273g-5p inhibit the epithelial-mesenchymal transition of transforming growth factor β2-mediated retinal pigment epithelial cells by targeting ATP-binding cassette A4
por: Dong, Hongtao, et al.
Publicado: (2021)

The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus
por: Zhang, Xingxing, et al.
Publicado: (2022)

Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta‐Analysis
por: Young, Steven, et al.
Publicado: (2020)

Independent Dose–Response Associations between Fetuin-A and Lean Nonalcoholic Fatty Liver Disease
por: Lu, Chia-Wen, et al.
Publicado: (2021)

Reduced Equol Production and Gut Microbiota Features in Men With Lean Nonalcoholic Fatty Liver Disease
por: Iino, Chikara, et al.
Publicado: (2022)

Unique genetic variants of lean nonalcoholic fatty liver disease: a retrospective cohort study
por: Li, Jie, et al.
Publicado: (2023)

Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality
por: Golabi, Pegah, et al.
Publicado: (2019)

Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects
por: Yun, Yeojun, et al.
Publicado: (2019)

Non-invasive predictors of prognosis of Asian patients with histopathologically-confirmed lean nonalcoholic fatty liver disease
por: Iritani, Soichi, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease in lean and obese patients in Saudi patients from a single center
por: Alsuhaibani, Khalid A., et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease and Risk of Early-Onset Vasomotor Symptoms in Lean and Overweight Premenopausal Women
por: Cho, Yoosun, et al.
Publicado: (2022)

A Pilot Study of Serum MicroRNAs Panel as Potential Biomarkers for Diagnosis of Nonalcoholic Fatty Liver Disease
por: Tan, Youwen, et al.
Publicado: (2014)

Vegetarian diet, food substitution, and nonalcoholic fatty liver
por: Chiu, Tina H., et al.
Publicado: (2018)

Elevated Serum miR-7, miR-9, miR-122, and miR-141 Are Noninvasive Biomarkers of Acute Pancreatitis
por: Lu, Pan, et al.
Publicado: (2017)

Sex-Specific Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients
por: Fan, Nengguang, et al.
Publicado: (2016)

Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
por: Kim, Tae Hyung, et al.
Publicado: (2021)

miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2016)

Circ_0057558 promotes nonalcoholic fatty liver disease by regulating ROCK1/AMPK signaling through targeting miR-206
por: Chen, Xi, et al.
Publicado: (2021)

Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup
por: Hsu, Chiao-Lin, et al.
Publicado: (2019)

Determination of “indeterminate score” measurements in lean nonalcoholic fatty liver disease patients from western Saudi Arabia
por: Khayyat, Yasir Mohammed
Publicado: (2021)

Outcomes of subjects who are lean, overweight or obese with nonalcoholic fatty liver disease: A cohort study in China
por: Lan, Yanqi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1bsi6vq5kspiilvoipd9bc1vee